Pathophysiological Roles of Amyloidogenic Carboxy-Terminal Fragments of the β-Amyloid Precursor Protein in Alzheimer’s Disease
- 1 January 2005
- journal article
- review article
- Published by Japanese Pharmacological Society in Journal of Pharmacological Sciences
- Vol. 97 (4) , 461-471
- https://doi.org/10.1254/jphs.cr0050014
Abstract
Several lines of evidence suggest that some of the neurotoxicity in Alzheimer's disease (AD) is attributed to proteolytic fragments of amyloid precursor protein (APP) and beta-amyloid (Abeta) may not be the sole active component involved in the pathogenesis of AD. The potential effects of other cleavage products of APP need to be explored. The CTFs, carboxy-terminal fragments of APP, have been found in AD patients' brain and reported to exhibit much higher neurotoxicity in a variety of preparations than Abeta. Furthermore CTFs are known to impair calcium homeostasis and learning and memory through blocking LTP, triggering a strong inflammatory reaction through MAPKs- and NF-kappaB-dependent astrocytosis and iNOS induction. Recently, it was reported that CTF translocated into the nucleus, binding with Fe65 and CP2, and in turn, affected transcription of genes including glycogen synthase kinase-3beta, which results in the induction of tau-rich neurofibrillary tangles and subsequently cell death. Spatial memory of transgenic (Tg) mice overexpressing CT100 was significantly impaired and CTFs were detected in the neurons as well as in plaques of the Tg mice and double Tg mice carrying CT100 and mutant tau. In this review, we summarize observations indicating that both CTF and Abeta may participate in the neuronal degeneration in the progress of AD by differential mechanisms.Keywords
This publication has 99 references indexed in Scilit:
- Alzheimer's disease and Down's syndrome: Sharing of a unique cerebrovascular amyloid fibril proteinPublished by Elsevier ,2004
- Amyloid ? protein is internalized selectively by hippocampal field CA1 and causes neurons to accumulate amyloidogenic carboxyterminal fragments of the amyloid precursor proteinJournal of Comparative Neurology, 1998
- Intracellular Generation of Amyloid β-Protein from Amyloid β-Protein Precursor Fragment by Direct Cleavage with β- and γ-SecretaseBiochemical and Biophysical Research Communications, 1996
- Expression of potentially amyloidogenic derivatives of the Alzheimer amyloid precursor protein in cultured 293 cellsNeuroscience Letters, 1994
- Altered cleavage and secretion of a recombinant β–APP bearing the Swedish familial Alzheimer's disease mutationNature Genetics, 1994
- Protease inhibitors generate cytotoxic fragments from alzheimer amyloid protein precursor in cDNA-transfected glioma cellsBiochemical and Biophysical Research Communications, 1992
- Overexpression of amyloid precursor protein alters its normal processing and is associated with neurotoxicityBiochemical and Biophysical Research Communications, 1992
- Abnormal and deficient processing of β-amyloid precursor protein in familial Alzheimer's disease lymphoblastoid cellsBiochemical and Biophysical Research Communications, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991
- Genomic organization of the human amyloid beta-protein precursor geneGene, 1990